Clinical Trials Directory

Trials / Completed

CompletedNCT02736383

Tranexamic Acid in Hip Fracture Surgery

Effectiveness of Tranexamic Acid (TXA) in Reducing Blood Loss in Hip Fracture Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
142 (actual)
Sponsor
Corewell Health West · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

To determine if TXA utilization is effective at reducing transfusion rates in elderly patients undergoing surgery for treatment of a hip fractures.

Conditions

Timeline

Start date
2016-05-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2016-04-13
Last updated
2023-09-22

Source: ClinicalTrials.gov record NCT02736383. Inclusion in this directory is not an endorsement.

Tranexamic Acid in Hip Fracture Surgery (NCT02736383) · Clinical Trials Directory